Familial Amyloid Polyneuropathy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BBIO | D | BridgeBio Pharma, Inc. | 0.19 | |
IONS | D | Ionis Pharmaceuticals, Inc. | -2.93 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Familial Amyloid Polyneuropathy stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 3.7 | |
BBP | D | BioShares Biotechnology Products Fund | 3.27 | |
WDNA | C | WisdomTree BioRevolution Fund | 3.02 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 2.87 | |
HELX | A | Franklin Genomic Advancements ETF | 2.83 |
Compare ETFs
Related Industries:
Biotechnology
- Familial Amyloid Polyneuropathy
Familial amyloid polyneuropathy (FAP), also called transthyretin-related hereditary amyloidosis, transthyretin amyloidosis abbreviated also as ATTR (hereditary form), or Corino de Andrade's disease, is an autosomal dominant neurodegenerative disease. It is a form of amyloidosis, and was first identified and described by Portuguese neurologist Mário Corino da Costa Andrade, in 1952. FAP is distinct from senile systemic amyloidosis (SSA), which is not inherited, and which was determined to be the primary cause of death for 70% of supercentenarians who have been autopsied.FAP can be ameliorated by liver transplantation.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles